ETHERNA

Welcome to the Brand page for “ETHERNA”, which is offered here for Custom manufacture of pharmaceutical and medical preparations; custom manufacture of mrna molecules; custom manufacture of mrna molecules formulated in lipid nanoparticles; custom manufacture of mrna for use in vaccines, cell therapy, gene editing, protein replacement, and antibodies; provision of information, advice and consultancy services relating to all of the aforesaid;vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, preparations containing messenger rna for preventing and treating viruses, medical disorders, and diseases; mrna-based therapeutics and therapeutic agents for in prevention and treatment of viruses, medical disorders, and diseases; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, messenger rna and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mrna to human cells;biological preparations for boosting cells in the immune system for improved therapies; biological preparations, a mrna-based composition for enhancing immunities; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use;scientific research and development; pharmaceutical research and development services; medical research and development services; scientific, pharmaceutical, and medical research and development in the field of mrna therapeutics; scientific, pharmaceutical, and medical research and development in the field of proprietary lipids and lipid nanoparticle formulations for the delivery of mrna therapeutics for the treatment of various medical disorders, cancer, and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “ETHERNA” is believed to be currently owned by “eTheRNA immunotherapies NV”.